化学合成。
医药中间体
合成路线 1(1. 合成:2450-26-2)
产率:96.3%
合成条件:With potassium carbonate In methanol at 20℃; for 2 h; Acidic aqueous solution
实验步骤:将4.54g [(L9。)[OMMOL]] 4-甲酰基-2-甲氧基-3-硝基苯基酯和5.24g(37.9mmol)碳酸钾在甲醇[40ML]中的混合物在室温下搅拌2小时。 将反应混合物倒入[WATER,-ACIDIFIED]的1N [HCl]溶液中并萃取到AcOEt中。 用盐水洗涤有机层,用[MGSO 4]干燥,过滤,蒸发溶剂。 用正己烷洗涤残余物,得到标题化合物3. [60G],为白色固体。 收率96.3%。
参考文献:
- [1] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 5, p. 1406 - 1410 [2] Patent: WO2004/29055, 2004, A1. Location in patent: Page 51 [3] Journal of Chemical Research, Miniprint, 1990, # 12, p. 2831 - 2867 [4] Patent: WO2016/71380, 2016, A1. Location in patent: Page/Page column 43 [5] Patent: WO2008/70150, 2008, A1. Location in patent: Page/Page column 65-66 [6] Patent: WO2012/62748, 2012, A1. Location in patent: Page/Page column 56 [7] Patent: WO2012/62743, 2012, A1. Location in patent: Page/Page column 60 [8] Patent: WO2012/62745, 2012, A1. Location in patent: Page/Page column 61 [9] ChemMedChem, 2016, p. 1517 - 1530 [10] Patent: US2015/266845, 2015, A1. Location in patent: Page/Page column 0051 [11] Patent: KR101770302, 2017, B1. Location in patent: Paragraph 0201; 0202 [12] Journal of Organic Chemistry, 1961, vol. 26, p. 4344 - 4347 [13] Chemical and pharmaceutical bulletin, 1965, vol. 13, # 2, p. 130 - 135 [14] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1993, # 17, p. 1967 - 1972 [15] Synthetic Communications, 1995, vol. 25, # 4, p. 569 - 572 [16] Journal of Physical Organic Chemistry, 2000, vol. 13, # 9, p. 511 - 517 [17] Tetrahedron Letters, 2000, vol. 41, # 49, p. 9369 - 9372 [18] Tetrahedron, 2002, vol. 58, # 17, p. 3423 - 3444 [19] Journal of Medicinal Chemistry, 2005, vol. 48, # 14, p. 4663 - 4669 [20] Organic Letters, 2006, vol. 8, # 14, p. 3117 - 3120 [21] Patent: US4287341, 1981, A [22] Tetrahedron, 2009, vol. 65, # 16, p. 3246 - 3260 [23] Medicinal Chemistry Research, 2014, vol. 23, # 6, p. 2985 - 2994 [24] Journal of the American Chemical Society, 2015, vol. 137, # 19, p. 6219 - 6225 [25] Patent: WO2016/71382, 2016, A1. Location in patent: Page/Page column 41 [26] Patent: JP5876570, 2016, B2. Location in patent: Paragraph 0407-0411 [27] Patent: CN107074876, 2017, A. Location in patent: Paragraph 0309; 0310; 0313 [28] RSC Advances, 2017, vol. 7, # 82, p. 52180 - 52186
合成路线 2(2. 合成:2450-26-2)
产率:72%
合成条件:Stage #1: With nitric acid In ethylene glycol at 5℃; for 3 h; Stage #2: at 100℃; for 0.17 h; Stage #3: With hydrogenchloride In water
实验步骤:4-羟基-3-甲氧基-2-硝基苯甲醛:将4-甲酰基-2-甲氧基苯基乙酸酯(0.194g,1mmol)加入到冰浴中的发烟HNO 3(1mL)的冷溶液中,其中乙二醇分小份。将反应混合物搅拌3小时,保持温度在5℃以下。然后,移去冷却浴,将反应物倒入冰中,在室温下搅拌混合物直至黄色固体沉淀完全。过滤沉淀物,用水洗涤,然后通过用2M KOH(3mL)溶液在100℃处理10分钟进行水解。冷却后,将反应混合物用浓盐酸酸化。用HCl得到4-羟基-3-甲氧基-2-硝基苯甲醛,为黄色沉淀,过滤并用水洗涤(142mg,72%):mp:112-115℃; 1H NMR([D6] DMSO):δ= 3.76(s,3H,OCH3),7.21(d,J = 8.2Hz,1H,ArH),7.71(d,J = 8.2Hz,1H,ArH),8.72( s,1H,CHO),11.83ppm(bs,1H,OH);。 C8H7NO5计算值:C 48.74,H 3.58,N 7.10,实测值:C 48.96,H 3.67,N 7.32。
参考文献:
- [1] Chemical and Pharmaceutical Bulletin, 2009, vol. 57, # 4, p. 368 - 376 [2] Journal of Heterocyclic Chemistry, 1986, vol. 23, # 6, p. 1805 - 1814 [3] European Journal of Medicinal Chemistry, 2011, vol. 46, # 2, p. 756 - 764 [4] Chemische Berichte, 1899, vol. 32, p. 3407 [5] Chemische Berichte, 1910, vol. 43, p. 2140 [6] Chemische Berichte, 1899, vol. 32, p. 3407 [7] Bulletin de la Societe Chimique de France, 1965, p. 1417 - 1423 [8] Organic Letters, 2006, vol. 8, # 14, p. 3117 - 3120 [9] Journal of Medicinal Chemistry, 2005, vol. 48, # 14, p. 4663 - 4669 [10] Tetrahedron, 2002, vol. 58, # 17, p. 3423 - 3444 [11] Tetrahedron Letters, 2000, vol. 41, # 49, p. 9369 - 9372 [12] Journal of Physical Organic Chemistry, 2000, vol. 13, # 9, p. 511 - 517 [13] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1993, # 17, p. 1967 - 1972 [14] Journal of Chemical Research, Miniprint, 1990, # 12, p. 2831 - 2867 [15] Chemical and pharmaceutical bulletin, 1965, vol. 13, # 2, p. 130 - 135 [16] Patent: US5866513, 1999, A [17] Patent: WO2012/62748, 2012, A1 [18] Patent: WO2012/62743, 2012, A1 [19] Medicinal Chemistry Research, 2014, vol. 23, # 6, p. 2985 - 2994 [20] Journal of the American Chemical Society, 2015, vol. 137, # 19, p. 6219 - 6225 [21] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 5, p. 1406 - 1410 [22] Patent: US2015/266845, 2015, A1 [23] Patent: WO2016/71382, 2016, A1 [24] Patent: WO2016/71380, 2016, A1 [25] ChemMedChem, 2016, p. 1517 - 1530 [26] Patent: JP5876570, 2016, B2 [27] Patent: CN107074876, 2017, A [28] Patent: KR101770302, 2017, B1 [29] RSC Advances, 2017, vol. 7, # 82, p. 52180 - 52186 [30] Patent: WO2012/62745, 2012, A1
合成路线 3(3. 合成:2450-26-2)
产率:62%
合成条件:Stage #1: With sulfuric acid; nitric acid In dichloromethane; water at 0 - 5℃; for 12 h; Microwave irradiation; Large scale Stage #2: With potassium carbonate In methanol; dichloromethane at 30℃; for 3 h; Large scale Stage #3: With hydrogenchloride In dichloromethane; water at 30℃; for 0.25 h; Large scale
实验步骤:通过在微反应器中对香草醛乙酸酯(1)进行流动硝化来合成2-硝基香兰素(2)。在0℃(硝化酸)下将3.94kg硝酸(65%)加入5.87kg浓硫酸中。将1.5kg乙酸奎宁酯溶于2.9kg二氯甲烷(乙酸香草醛溶液)中。两种溶液在微反应器中以app的流速反应。 8.0 mL / min(硝化酸)和app。在5℃下,4.0mL / min(乙酸香草醛溶液)。将反应混合物直接加入到3kg的8kg水中。 3小时后,将流速增加至10mL / min(硝化酸)和5.0mL / min(乙酸香草醛溶液)。再过9小时后,流动反应完成。在室温下分离各层,水相用2L二氯甲烷萃取。将合并的有机相用2L饱和碳酸氢钠洗涤,然后用0.8L水洗涤。将二氯甲烷溶液真空浓缩至至少。加入3L,3.9L甲醇和app。通过蒸馏再次除去相同的体积。加入另外的3.9L甲醇,并将溶液浓缩至一定体积的app。加入3.5L 1.25kg甲醇,然后加入2.26kg碳酸钾。将混合物在30℃搅拌3小时。在<30(pH 0.5-1)下加入7.3千克二氯甲烷和12.8千克盐酸水溶液(10毫升)。将混合物搅拌15分钟,分离各层。过滤有机层,滤饼用0.5L二氯甲烷洗涤。将水层用4.1kg二氯甲烷萃取两次。将合并的有机层真空浓缩至app。加入4L 3.41kg甲苯,并将混合物浓缩至最终体积。将混合物冷却至0℃.90分钟后,过滤悬浮液。将收集的固体用冷甲苯洗涤并干燥,得到0.95kg(62%)。 1 H-NMR(400MHz,脱DMSO):δ= 3.84(s,3H),7.23(d,1H),7.73(d,1H),9.74(s,1H),11.22。 (brs,1 H)。
参考文献:
- [1] Patent: WO2016/71426, 2016, A1. Location in patent: Page/Page column 32-33 [2] Patent: WO2016/71435, 2016, A2. Location in patent: Page/Page column 47-48 [3] Patent: JP2018/8900, 2018, A. Location in patent: Paragraph 0081; 0082; 0084; 0085